XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   13,986,000        
Beginning balance at Dec. 31, 2022 $ 2,596 $ 1 $ (34,251) $ 388,184 $ 181 $ (351,519)
Beginning balance (in shares) at Dec. 31, 2022     1,021,000      
Increase (Decrease) in Equity            
Net income 22,609         22,609
Foreign currency translation adjustment 13       13  
Stock issued under employee stock purchase plan (in shares)     (12,000)      
Stock issued under employee stock purchase plan 48     48    
Restricted stock units vested (in shares)   82,000        
Restricted stock granted (in shares)   148,000        
Restricted stock forfeited (in shares)   7,000 65,000      
Forfeited stock options purchased (617)     (617)    
Stock compensation expense (565)     (565)    
Shares withheld to cover taxes (in shares)   (3,000) (36,000)      
Shares withheld to cover taxes (246)   $ (231) (15)    
Exercise of pre-funded warrants (in shares)   4,228,000        
Issuance of stock warrants, net of transaction fee 15,092     15,092    
Conversion of convertible notes payable to Pre-Funded Warrants 11,040     11,040    
Conversion of convertible notes payable to Common Stock (in shares)   1,723,000        
Conversion of convertible notes payable to Common Stock 8,996     8,996    
Conversion of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable to Common Stock (in shares)   10,583,000        
Conversion of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable to Common Stock 40,638 $ 2   40,636    
Ending balance (in shares) at Sep. 30, 2023   30,740,000        
Ending balance at Sep. 30, 2023 99,604 $ 3 $ (34,482) 462,799 194 (328,910)
Ending balance (in shares) at Sep. 30, 2023     1,110,000      
Beginning balance (in shares) at Jun. 30, 2023   26,370,000        
Beginning balance at Jun. 30, 2023 98,002 $ 3 $ (34,480) 462,529 147 (330,197)
Beginning balance (in shares) at Jun. 30, 2023     1,113,000      
Increase (Decrease) in Equity            
Net income 1,287         1,287
Foreign currency translation adjustment 47       47  
Stock issued under employee stock purchase plan (in shares)     (4,000)      
Stock issued under employee stock purchase plan 15     15    
Restricted stock granted (in shares)   145,000        
Restricted stock forfeited (in shares)     1,000      
Stock compensation expense 270     270    
Shares withheld to cover taxes (in shares)   (3,000)        
Shares withheld to cover taxes (17)   $ (2) (15)    
Exercise of pre-funded warrants (in shares)   4,228,000        
Ending balance (in shares) at Sep. 30, 2023   30,740,000        
Ending balance at Sep. 30, 2023 $ 99,604 $ 3 $ (34,482) 462,799 194 (328,910)
Ending balance (in shares) at Sep. 30, 2023     1,110,000      
Beginning balance (in shares) at Dec. 31, 2023 30,772,837 30,773,000        
Beginning balance at Dec. 31, 2023 $ 101,960 $ 3 $ (34,504) 463,140 127 (326,806)
Beginning balance (in shares) at Dec. 31, 2023 1,108,707   1,109,000      
Increase (Decrease) in Equity            
Net income $ 6,068         6,068
Foreign currency translation adjustment 6       6  
Stock issued under employee stock purchase plan (in shares)     (25,000)      
Stock issued under employee stock purchase plan 88     88    
Restricted stock units vested (in shares)   25,000        
Restricted stock granted (in shares)   94,000        
Restricted stock forfeited (in shares)     11,000      
Stock compensation expense 915     915    
Shares withheld to cover taxes (in shares)     (7,000)      
Shares withheld to cover taxes $ (30)   $ (30)      
Ending balance (in shares) at Sep. 30, 2024 30,891,597 30,892,000        
Ending balance at Sep. 30, 2024 $ 109,007 $ 3 $ (34,534) 464,143 133 (320,738)
Ending balance (in shares) at Sep. 30, 2024 1,102,121   1,102,000      
Beginning balance (in shares) at Jun. 30, 2024   30,867,000        
Beginning balance at Jun. 30, 2024 $ 106,234 $ 3 $ (34,528) 463,844 185 (323,270)
Beginning balance (in shares) at Jun. 30, 2024     1,107,000      
Increase (Decrease) in Equity            
Net income 2,532         2,532
Foreign currency translation adjustment (52)       (52)  
Stock issued under employee stock purchase plan (in shares)     (6,000)      
Stock issued under employee stock purchase plan 26     26    
Restricted stock units vested (in shares)   25,000        
Stock compensation expense 273     273    
Shares withheld to cover taxes (in shares)     (1,000)      
Shares withheld to cover taxes $ (6)   $ (6)      
Ending balance (in shares) at Sep. 30, 2024 30,891,597 30,892,000        
Ending balance at Sep. 30, 2024 $ 109,007 $ 3 $ (34,534) $ 464,143 $ 133 $ (320,738)
Ending balance (in shares) at Sep. 30, 2024 1,102,121   1,102,000